Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01849146
Title WEE1 Inhibitor MK-1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
UCSF Medical Center-Parnassus San Francisco California 94143 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field